Bogacka, J., Ciapała, K., Pawlik, K., Kwiatkowski, K., Dobrogowski, J., Przeklasa-Muszynska, A., & Mika, J. (2020). CCR4 Antagonist (C021) Administration Diminishes Hypersensitivity and Enhances the Analgesic Potency of Morphine and Buprenorphine in a Mouse Model of Neuropathic Pain. Front Immunol.
Styl cytowania ChicagoBogacka, Joanna, Katarzyna Ciapała, Katarzyna Pawlik, Klaudia Kwiatkowski, Jan Dobrogowski, Anna Przeklasa-Muszynska, i Joanna Mika. "CCR4 Antagonist (C021) Administration Diminishes Hypersensitivity and Enhances the Analgesic Potency of Morphine and Buprenorphine in a Mouse Model of Neuropathic Pain." Front Immunol 2020.
Styl cytowania MLABogacka, Joanna, et al. "CCR4 Antagonist (C021) Administration Diminishes Hypersensitivity and Enhances the Analgesic Potency of Morphine and Buprenorphine in a Mouse Model of Neuropathic Pain." Front Immunol 2020.